-+ 0.00%
-+ 0.00%
-+ 0.00%

Innovent Biologics Unveils Promising Phase 1 Results for Trispecific Antibody IBI3003 in Relapsed Multiple Myeloma

Reuters·12/08/2025 01:03:20

Please log in to view news